BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35023102)

  • 21. Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
    Spijkers-Hagelstein JA; Schneider P; Hulleman E; de Boer J; Williams O; Pieters R; Stam RW
    Leukemia; 2012 Jun; 26(6):1255-65. PubMed ID: 22282267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells.
    Tissing WJ; den Boer ML; Meijerink JP; Menezes RX; Swagemakers S; van der Spek PJ; Sallan SE; Armstrong SA; Pieters R
    Blood; 2007 May; 109(9):3929-35. PubMed ID: 17218380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
    Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
    PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Prednisolone on miR 15a and miR16-1 Expression Levels and Apoptosis in Acute Lymphoblastic Leukemia Cell Line: CCRF-CEM.
    Azimi A; Hagh MF; Yousefi B; Rahnama MA; Khorrami A; Heydarabad MZ; Najafpour M; Hallajzadeh J; Ghahremani A
    Drug Res (Stuttg); 2016 Aug; 66(8):432-5. PubMed ID: 27281445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
    Styczynski J; Kurylak A; Wysocki M
    Anticancer Res; 2005; 25(3B):2253-8. PubMed ID: 16158972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia.
    Beesley AH; Rampellini JL; Palmer ML; Heng JY; Samuels AL; Firth MJ; Ford J; Kees UR
    Mol Cancer; 2010 Oct; 9():284. PubMed ID: 20979663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.
    Pottier N; Yang W; Assem M; Panetta JC; Pei D; Paugh SW; Cheng C; Den Boer ML; Relling MV; Pieters R; Evans WE; Cheok MH
    J Natl Cancer Inst; 2008 Dec; 100(24):1792-803. PubMed ID: 19066270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.
    Stam RW; Den Boer ML; Schneider P; de Boer J; Hagelstein J; Valsecchi MG; de Lorenzo P; Sallan SE; Brady HJ; Armstrong SA; Pieters R
    Blood; 2010 Feb; 115(5):1018-25. PubMed ID: 19965632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory effect of resveratrol and prednisolone on MDR1 gene expression in acute lymphoblastic leukemia cell line (CCRF-CEM): An epigenetic perspective.
    Zadi Heydarabad M; Nikasa M; Vatanmakanian M; Azimi A; Farshdousti Hagh M
    J Cell Biochem; 2018 Jun; 119(6):4890-4896. PubMed ID: 29377275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia.
    Holleman A; den Boer ML; de Menezes RX; Cheok MH; Cheng C; Kazemier KM; Janka-Schaub GE; Göbel U; Graubner UB; Evans WE; Pieters R
    Blood; 2006 Jan; 107(2):769-76. PubMed ID: 16189266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EgoNet identifies differential ego-modules and pathways related to prednisolone resistance in childhood acute lymphoblastic leukemia.
    Jiang J; Yin XY; Song XW; Xie D; Xu HJ; Yang J; Sun LR
    Hematology; 2018 May; 23(4):221-227. PubMed ID: 29019453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
    Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
    Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia.
    Ploner C; Schmidt S; Presul E; Renner K; Schröcksnadel K; Rainer J; Riml S; Kofler R
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):153-60. PubMed ID: 15860257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circumvention of glucocorticoid resistance in childhood leukemia.
    Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
    Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia.
    Tissing WJ; Lauten M; Meijerink JP; den Boer ML; Koper JW; Sonneveld P; Pieters R
    Haematologica; 2005 Sep; 90(9):1279-81. PubMed ID: 16154856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia.
    Mousavian Z; Nowzari-Dalini A; Stam RW; Rahmatallah Y; Masoudi-Nejad A
    Cell Oncol (Dordr); 2017 Feb; 40(1):33-45. PubMed ID: 27798768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.
    Wei G; Twomey D; Lamb J; Schlis K; Agarwal J; Stam RW; Opferman JT; Sallan SE; den Boer ML; Pieters R; Golub TR; Armstrong SA
    Cancer Cell; 2006 Oct; 10(4):331-42. PubMed ID: 17010674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL.
    Tissing WJ; Meijerink JP; Brinkhof B; Broekhuis MJ; Menezes RX; den Boer ML; Pieters R
    Blood; 2006 Aug; 108(3):1045-9. PubMed ID: 16574952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer.
    Gasca J; Flores ML; Giráldez S; Ruiz-Borrego M; Tortolero M; Romero F; Japón MA; Sáez C
    Oncotarget; 2016 Aug; 7(33):52751-52765. PubMed ID: 27409838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis.
    Styczynski J; Koltan A; Wysocki M
    Neoplasma; 2006; 53(2):168-73. PubMed ID: 16575474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.